Literature DB >> 12500303

Evaluation of SDF-1/CXCR4-induced Ca2+ signaling by fluorometric imaging plate reader (FLIPR) and flow cytometry.

Katrien Princen1, Sigrid Hatse, Kurt Vermeire, Erik De Clercq, Dominique Schols.   

Abstract

BACKGROUND: The chemokine receptors CXCR4 and CCR5 are the main coreceptors for human immunodeficiency virus (HIV) 1 to enter its target cells. The antiviral activity of their natural ligands (stromal cell-derived factor 1 [SDF-1], regulated on activation normal T-cell expressed and secreted, (RANTES) and macrophage inflammatory proteins 1alpha and 1beta, MIP-1alpha and MIP-1beta) and the finding that individuals deficient in CCR5 are relatively resistant to HIV infection led to the concept that chemokine receptor antagonists can play an important role in anti-HIV therapy. AMD3100, the prototype compound of the bicyclams, is one of the most potent and selective CXCR4 antagonists described to date. The search for new chemokine receptor antagonists involves the evaluation of compounds for their ability to block the specific chemokine-induced transient intracellular Ca(2+) flux. We evaluated two cell-based-fluorescent methods with the use of the Fluorometric Imaging Plate Reader (FLIPR) system and a flow cytometric assay to measure the SDF-1-induced intracellular Ca(2+) mobilization via CXCR4. Both assay systems were compared for their sensitivity, advantages, and system-dependent limitations.
METHODS: CXCR4(+) lymphocytic and monocytic cell lines commonly used in laboratories studying acquired immunodeficiency syndrome and freshly isolated peripheral blood mononuclear cells (PBMCs) were loaded with the Ca(2+) indicator Fluo-3. After washing, the cells were preincubated with the CXCR4 antagonist AMD3100. Then the increase in intracellular Ca(2+) concentration after stimulation with SDF-1 was examined by the FLIPR and the flow cytometer, which monitored the change in green fluorescence intensity of Ca(2+)-bound Fluo-3. Surface CXCR4 expression was also determined flow cytometrically.
RESULTS: In all five CXCR4(+) cell lines, SDF-1 elicited a transient increase in intracellular Ca(2+) concentration. For each cell line, the magnitude of response was related to the level of CXCR4 expression: the cells with the highest CXCR4 level showed the strongest Ca(2+) response. AMD3100 effected a dose-dependent inhibition of the SDF-1-induced Ca(2+) flux in all cell lines examined. The FLIPR was more sensitive than the flow cytometer in detecting minor Ca(2+) responses. In freshly isolated PBMCs, the Ca(2+) response was due solely to the stimulation of monocytes and granulocytes, whereas the lymphocyte population, although expressing CXCR4, did not respond at all. This phenomenon could be observed with the flow cytometer and not with the FLIPR.
CONCLUSIONS: The FLIPR system is a most adequate to monitor intracellular Ca(2+) mobilization and to evaluate chemokine receptor antagonists. However, flow cytometry and its multiparameter analysis allow additional characterization of the cells involved in the chemokine receptor-mediated signal transduction. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12500303     DOI: 10.1002/cyto.a.10008

Source DB:  PubMed          Journal:  Cytometry A        ISSN: 1552-4922            Impact factor:   4.355


  20 in total

Review 1.  Fugetaxis: active movement of leukocytes away from a chemokinetic agent.

Authors:  Fabrizio Vianello; Ivona T Olszak; Mark C Poznansky
Journal:  J Mol Med (Berl)       Date:  2005-09-03       Impact factor: 4.599

2.  7-ketocholesterol incorporation into sphingolipid/cholesterol-enriched (lipid raft) domains is impaired by vitamin E: a specific role for alpha-tocopherol with consequences on cell death.

Authors:  Marie-Charlotte Royer; Stéphanie Lemaire-Ewing; Catherine Desrumaux; Serge Monier; Jean-Paul Pais de Barros; Anne Athias; Dominique Néel; Laurent Lagrost
Journal:  J Biol Chem       Date:  2009-04-07       Impact factor: 5.157

3.  Different contributions of chemokine N-terminal features attest to a different ligand binding mode and a bias towards activation of ACKR3/CXCR7 compared with CXCR4 and CXCR3.

Authors:  Martyna Szpakowska; Amanda M Nevins; Max Meyrath; David Rhainds; Thomas D'huys; François Guité-Vinet; Nadine Dupuis; Pierre-Arnaud Gauthier; Manuel Counson; Andrew Kleist; Geneviève St-Onge; Julien Hanson; Dominique Schols; Brian F Volkman; Nikolaus Heveker; Andy Chevigné
Journal:  Br J Pharmacol       Date:  2018-03-23       Impact factor: 8.739

4.  Transforming growth factor-{beta}1 modulates responses of CD34+ cord blood cells to stromal cell-derived factor-1/CXCL12.

Authors:  Sunanda Basu; Hal E Broxmeyer
Journal:  Blood       Date:  2005-03-29       Impact factor: 22.113

5.  CCR8+FOXp3+ Treg cells as master drivers of immune regulation.

Authors:  Yiftah Barsheshet; Gizi Wildbaum; Eran Levy; Alon Vitenshtein; Chika Akinseye; Jeremy Griggs; Sergio A Lira; Nathan Karin
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-22       Impact factor: 11.205

Review 6.  CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression.

Authors:  Xueqing Sun; Guangcun Cheng; Mingang Hao; Jianghua Zheng; Xiaoming Zhou; Jian Zhang; Russell S Taichman; Kenneth J Pienta; Jianhua Wang
Journal:  Cancer Metastasis Rev       Date:  2010-12       Impact factor: 9.264

7.  The monomer-dimer equilibrium of stromal cell-derived factor-1 (CXCL 12) is altered by pH, phosphate, sulfate, and heparin.

Authors:  Christopher T Veldkamp; Francis C Peterson; Adam J Pelzek; Brian F Volkman
Journal:  Protein Sci       Date:  2005-03-01       Impact factor: 6.725

8.  Aspartate-Based CXCR4 Chemokine Receptor Binding of Cross-Bridged Tetraazamacrocyclic Copper(II) and Zinc(II) Complexes.

Authors:  Randall D Maples; Amy N Cain; Benjamin P Burke; Jon D Silversides; Ryan E Mewis; Thomas D'huys; Dominique Schols; Douglas P Linder; Stephen J Archibald; Timothy J Hubin
Journal:  Chemistry       Date:  2016-07-26       Impact factor: 5.236

9.  Structural basis of CXCR4 sulfotyrosine recognition by the chemokine SDF-1/CXCL12.

Authors:  Christopher T Veldkamp; Christoph Seibert; Francis C Peterson; Norberto B De la Cruz; John C Haugner; Harihar Basnet; Thomas P Sakmar; Brian F Volkman
Journal:  Sci Signal       Date:  2008-09-16       Impact factor: 8.192

10.  CCR5 ligands modulate CXCL12-induced chemotaxis, adhesion, and Akt phosphorylation of human cord blood CD34+ cells.

Authors:  Sunanda Basu; Hal E Broxmeyer
Journal:  J Immunol       Date:  2009-11-16       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.